Blüm Holdings Inc. Reports Second Quarter 2024 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News
51
Blüm Holdings Inc. Reports Second Quarter 2024 Financial Results, Showcasing Strategic Progress and Net Income of $23.4 Million

SANTA ANA, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Blüm Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm Holdings,” “we” or “us”), a cannabis company with subsidiaries operating throughout California, announced its financial results for the second quarter ended June 30, 2024. These results not only reflect our strong financial performance but also underscore the effectiveness of our ongoing strategic restructuring, debt reduction, and operational streamlining.

Second Quarter 2024 Highlights

  • Transformative Sale of Blüm Santa Ana:  In June 2024, we completed the sale of our controlling interest in People’s First Choice, LLC ("PFC"), which owns and operates the Blüm Santa Ana dispensary, to Haven Nectar LLC. This sale, a pivotal move in our restructuring strategy, provided $24.8 million in total consideration, including $9.0 million in cash and $15.8 million in assumed liabilities. The transaction significantly bolstered our balance sheet, eliminating an estimated $37.9 million in liabilities and contributing to a total liability reduction of approximately $63.3 million since December 31, 2021. This transaction resulted in a $31.7 million non-cash gain, or $3.46 per share.
  • Robust Financial Turnaround:  As a direct result of this transaction, Blüm Holdings achieved a net income of $23.4 million for the second fiscal quarter of 2024. This marks a significant shift from our prior financial position and highlights the effectiveness of our management team. While our Adjusted EBITDA for the quarter was a loss of $3.7 million, this figure excludes the one-time gain from the sale and other non-cash items, reflecting our continued focus on operational efficiency.
  • Continued Focus on Core Assets:  Our strategy to optimize our asset portfolio continued with the agreement to sell The Spot, our other Santa Ana retail dispensary. Additionally, we successfully launched operations at three new dispensaries in Northern California, beginning in May 2024 and contributing $2.1 million in revenue through June 30, 2024. These efforts are part of our broader strategy to focus on higher-performing assets and expand our presence in key markets.
  • Improved Financial Position and Margins:  Blüm Holdings reported $7.2 million in total revenue for the quarter, including $2.1 million in revenue from the three new dispensaries in Northern California and $3.5 million from discontinued operations, an increase from $6.9 million in the previous quarter. Our gross margin, although slightly down to 42% from 45% in the first fiscal quarter of 2024 due to initial discounting at new locations, is expected to improve as we refine our pricing strategies.
  • Expense Reduction and Debt Management : Since August 2022 when new management took over, Blüm Holdings has made substantial progress in reducing both operating expenses and overall liabilities. As of June 30, 2024, our debt stood at $9.4 million, which includes the debt assumed with the new Northern California dispensaries, down from $29.1 million at the end of 2023 and significantly lower than $55.8 million at the end of 2021. This 83% reduction in debt over the past three years highlights our disciplined approach to financial management. Additionally, lease liabilities have been reduced by nearly 58% to $4.1 million since the 2023 year-end, continuing our strategy to streamline operations and reduce financial burdens.
  • Comparative Financial Improvement:  In August 2022, Blüm Holdings faced a total liability burden of $125.3 million, as reported on December 31, 2021. By the end of 2023, we had successfully reduced this figure to $77.8 million, and as of June 30, 2024, we have further decreased our total liabilities to $62.1 million. This reduction along with a focus on high-margin products reflects our commitment to strategic asset management, cost efficiency, and the elimination of underperforming operations. Furthermore, our gross profit margin has improved significantly from 25% in 2021 to 53% by the end of 2023, with continued steady performance into 2024, underscoring the success of our operational initiatives.

Patty Chan, Chief Financial Officer of Blüm Holdings, stated: “The sale of Blüm Santa Ana along with our financial results this quarter are not just financial milestones; they mark the culmination of the transformative journey we began in August 2022. We faced significant challenges—a broken culture, excessive debt, underperforming assets, and a need for strategic clarity. Through disciplined execution and consistent hard work, we have reduced our debt, streamlined our operations, and positioned Blüm Holdings for sustained growth and profitability. Our success in executing these strategies, despite limited capital, is a testament to the dedication and expertise of our management team.”

Sabas Carrillo, Chief Executive Officer of Blüm Holdings, added: “With the new stores, Blüm Holdings is beginning to capitalize on new opportunities in the California cannabis market. Our streamlined operations, reduced debt load, and expanded retail footprint provide a robust platform for sustained growth and profitability. As we approach the two-year anniversary of when our team took over, I believe we have achieved a strong track record of being responsible stewards of the assets and investments entrusted to us. We deeply appreciate the support of our partners who joined us at the beginning, our new partners and those who may be joining us. Their confidence in our vision and capabilities reinforces our commitment to driving long-term value for all stakeholders. We are confident that our strategic focus and operational discipline will continue to drive value for our shareholders as we move forward.”

About Blüm Holdings

Blüm Holdings is a leader in the cannabis sector. Our commitment to quality, innovation, and customer service makes us a trusted name in the cannabis industry, dedicated to shaping its future. Blüm Holdings, through its subsidiaries, operates leading dispensaries throughout California as well as several leading company-owned brands including Korova, known for its high potency products across multiple product categories, including the legendary 1000 mg THC Black Bar.

For more info, please visit: https://blumholdings.com .

Contact: Jason Assad LR Advisors LLC. jassad@blumholdings.com 678-570-6791

Non-GAAP Financial Information

This press release includes certain non-GAAP financial measures as defined by the U.S. Securities and Exchange Commission (the “SEC”). Management believes that these non-GAAP financial measures assess the Company’s ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business, as they facilitate comparing financial results across accounting periods and to those of peer companies. These non-GAAP financial measures exclude certain material non-cash items and certain other adjustments the Company believes are not reflective of its ongoing operations and performance. Management uses non-GAAP financial measures, in addition to GAAP financial measures, to understand operational decision-making, for planning and forecasting purposes, and to evaluate the Company’s financial performance. Management believes that these non-GAAP financial measures enhance investors’ understanding of the Company’s financial and operating performance and enable investors to evaluate the Company’s operating results and future prospects in the same manner as management. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated and presented in accordance with GAAP are included in the financial schedules attached to this press release. This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP.

Cautionary Language Concerning Forward-Looking Statements

Certain statements contained in this communication regarding matters that are not historical facts, are forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, known as the PSLRA. These include statements regarding management's intentions, plans, beliefs, expectations, or forecasts for the future, and, therefore, you are cautioned not to place undue reliance on them. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by law. The Company uses words such as “anticipates,” “believes,” “plans,” “expects,” “projects,” “future,” “intends,” “may,” “will,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “guidance,” and similar expressions to identify these forward-looking statements that are intended to be covered by the safe-harbor provisions of the PSLRA. Such forward-looking statements are based on the Company’s expectations and involve risks and uncertainties; consequently, actual results may differ materially from those expressed or implied in the statements due to a number of factors.

New factors emerge from time-to-time and it is not possible for the Company to predict all such factors, nor can the Company assess the impact of each such factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. These risks, as well as other risks associated with the combination, will be more fully discussed in the Company’s reports with the SEC. Additional risks and uncertainties are identified and discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other documents filed from time to time with the SEC. Forward-looking statements included in this release are based on information available to the Company as of the date of this release. The Company undertakes no obligation to update such forward-looking statements to reflect events or circumstances after the date of this release.

 
    (in thousands)
    June 30, 2024   December 31, 2023
Current Assets   $ 4,450     $ 4,693  
Long-Term Assets     33,801       27,378  
Total Assets   $ 38,251     $ 32,071  
         
Current Liabilities   $ 49,701     $ 62,548  
Long-Term Liabilities     12,355       15,219  
Total Liabilities     62,056       77,767  
         
Stockholders' Deficit     (23,805 )     (45,696 )
         
Total Liabilities and Stockholders' Deficit   $ 38,251     $ 32,071  
         
    (in thousands)
    Three Months Ended
    June 30, 2024   March 31, 2024
Revenue   $ 3,795     $ 1,774  
Cost of Goods Sold     2,203       976  
Gross Profit   $ 1,592     $ 798  
Gross Profit %     42 %     45 %
         
Operating Expenses     8,174       4,219  
Loss from Operations     (6,582 )     (3,421 )
         
Less: Other (Income) Expense     (13,976 )     (105 )
Income (Loss) from Continuing Operations Before Taxes     7,394       (3,316 )
         
Provision for Income Tax Expense for Continuing Operations     (262 )     (52 )
Net Income (Loss) from Continuing Operations   $ 7,132     $ (3,368 )
         
Net Income from Discontinued Operations, Net of Tax     16,232       317  
Net Income (Loss)   $ 23,364     $ (3,051 )
         
Non-Controlling Interests     (479 )     -  
Net Income (Loss) Attributable to Blum Holdings, Inc.   $ 23,843     $ (3,051 )
         
Basic and Diluted Loss per Share:        
Net Income (Loss) from Continuing Operations per Common Share - Basic   $ 0.78     $ (0.34 )
Net Income (Loss) from Continuing Operations per Common Share - Diluted   $ 0.65     $ (0.34 )
     
    (in thousands)
    Three Months Ended
    June 30,   March 31,
    2024   2024
Net Income (Loss)   $ 23,364     $ (3,051 )
Less: Net Income (Loss) from Discontinued Operations, Net     (16,232 )     (317 )
Add (Deduct) Impact of:        
Interest Expense     750       377  
Provision for Income Tax Expense     262       52  
Depreciation Expense     224       58  
Amortization of Intangible Assets     33       -  
EBITDA Income (Loss) from Continuing Operations (Non-GAAP)   $ 8,401     $ (2,881 )
         
Non-GAAP Adjustments:        
Stock-based Compensation Expense     316       110  
Impairment of Assets     1,709       -  
Severance Expense     -       37  
Unrealized (Gain) Loss on Investments     770       (417 )
Loss on Disposal of Assets     134       -  
Change in Fair Value of Derivative Liability     130       -  
Gain on Extinguishment of Debt     (15,182 )     -  
Adjusted EBITDA Loss from Continuing Operations (Non-GAAP)   $ (3,722 )   $ (3,151 )
         
    (in thousands)
    Three Months Ended
    June 30, 2024   March 31, 2024
Continuing Operations   $ 3,795     $ 1,774  
Discontinued Operations     3,451       5,080  
Total Revenue (Non-GAAP)   $ 7,246     $ 6,854  
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Q32 Bio Eyes New Horizons with Bempikibart's Potentials

Updated Category News Views 69

Q32 Bio Steers Forward: New Insights from Chief Results Today's update isn't just another quarterly snooze-fest—it’s a nudge in a crucial direction for Q32 Bio (NASDAQ:QTTB). After a bold brush with the European Academy of Dermatology and Venereology (EADV) Congress 2026, the company laid out a plan and a half, showing its hand with bempikibart for alopecia areata...

Continue Reading
First Industrial Declares Regular Dividend Amid Growth Insights

Updated Category News Views 116

Dividend Declaration Reflects Confidence First Industrial Realty Trust, folks, just put another office stamp on their ongoing reliability quest—and I'm talking dividends. They're shelling out a tidy $0.50 per share for Q4 2026, with stockholders due to see the cash on January 19, 2027. That's like clockwork precision, showing a steadiness in what some call the unruly...

Continue Reading
Toufayan's Sourdough Pita: A Century-Old Recipe Revival

Updated Category News Views 23

Crafting Tradition in Modern Times Ever see a family business stick to its roots despite the whirlwind of fleeting trends? Step aside, because Toufayan isn’t just baking bread—they're pulling a Houdini act, bringing a recipe out of the past and into our grocery aisles. By launching their Simply Sourdough pita, these folks are banking on good ol’ nostalgia and...

Continue Reading
Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Updated Category News Views 55

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 28

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading
Acuity Analytics Charts Ambitious AI-Driven Future

Updated Category News Views 128

The New Era at Acuity Analytics Has Begun Isn't it something when a company decides to shake things up in such a daring way? Acuity Analytics just gave the financial sector a reason to sit up and pay attention. They've brought in Jon O'Donnell as the new Chief Executive Officer, a move that's got the city talking. O'Donnell is no rookie; he's a former IBM heavyweight and...

Continue Reading
A Journey Through Mongolia's Wilderness and Self-Discovery

Updated Category News Views 57

A Late-Life Adventure Without Borders We all hit that age where adventure seems just a memory—until something shakes us from our slumber, just like Betsy Cooksey’s wild ride into Mongolia. At an age when most tether their dreams to sunlit porches and grandkids' photos, Cooksey grabbed life by the reins. First, though, we gotta talk about the absolute gamble she took....

Continue Reading
Lone Star's Debrief IQ: Revamping Military Training

Updated Category News Views 20

A Milestone for Military Pilot Training In the grand scheme of military pilot training, Debrief IQ from Lone Star Analysis is making waves. Apparently, they're shaving off a hefty 35 minutes of the grind instructors typically endure post-training sessions. I bet the flight schools are letting out a collective sigh of relief. Years of Frustration Handled by AI So, what's...

Continue Reading
Tigo Energy Faces Legal Heat Over Fraud Allegations

Updated Category News Views 142

Tigo Energy's Legal Battle Heats Up If you haven't been paying attention, it’s time to get your eyes on Tigo Energy (NASDAQ: TYGO). The company is now in the hot seat with a securities fraud lawsuit that's got investors on edge. This isn’t just a minor squabble; we're talking about allegations that could shake the ground beneath its share price. The Claims and...

Continue Reading
AI Shift: From Tech Marvels to Practical Uses

Updated Category News Views 80

A New Chapter in the AI Narrative Take a seat, folks, because we're watching AI swing from showy tech to something as plain as plumbing infrastructure. Imagine models that once cost bundles per token now going for peanuts. We're talking a nosedive from $37.50 to a mere 18 cents. It’s a seismic shift, steering the conversation from 'Are they the best models?' to 'How...

Continue Reading

Top 5 Most Recently Viewed Articles

Angel Oak Financial Strategies Hits New High of $13.35

Updated Category News Views 193

Angel Oak Financial Strategies Reaches New Heights Shares of Angel Oak Financial Strategies (FINS) have achieved a remarkable milestone by reaching a 52-week high, trading at an impressive $13.35. This significant growth is a testament to the company’s strong performance in the financial market. Investors are celebrating as they witness this increase, which stands as a...

Continue Reading
Indonesian Market Update: IDX Composite Index Drop Analyzed

Updated Category News Views 263

Overview of the Indonesian Stock Market's Recent Performance On a recent trading day, the Indonesian stock market experienced a notable decline, with the IDX Composite Index sliding 1.08%. This downtrend was largely influenced by losses in significant sectors such as Financials, Infrastructure, and Agriculture. Understanding these dynamics is essential for investors and...

Continue Reading
Eagle Bancorp Teams Up for Major Financial Conference in November

Updated Category News Views 103

Eagle Bancorp to Feature at Notable Financial Conference Eagle Bancorp, Inc. (NASDAQ: EGBN), the prominent holding company of EagleBank, is gearing up to participate in an influential financial event. This conference, the Piper Sandler East Coast Financial Services Conference, takes place over several days, offering a platform for significant discussions within the...

Continue Reading
Breathe Drops: A Game-Changer for Respiratory Wellness

Updated Category News Views 295

Introducing Breathe Drops: A Revolutionary Wellness Solution In the ever-evolving world of wellness, Breathe is thrilled to unveil its latest product, Breathe Drops. This unique formula aims to enhance lung health and respiratory wellness by harnessing the power of carefully selected natural ingredients. Designed for individuals seeking natural wellness solutions, Breathe...

Continue Reading
Keros Therapeutics to Showcase Innovations at Health Conference

Updated Category News Views 132

Keros Therapeutics to Showcase Innovations at Health Conference During an important upcoming event, Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, will highlight its ongoing commitment to developing novel therapeutics aimed at treating conditions tied to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) protein...

Continue Reading